TY - JOUR
T1 - Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell transplantation
T2 - Results of an international survey
AU - Toro, Juan J.
AU - Morales, Manuel
AU - Loberiza, Fausto
AU - Ochoa-Bayona, Jose L.
AU - Freytes, Cesar O.
N1 - Funding Information:
There was also uniformity in the approach to infection and thrombosis prophylaxis. Of the centers, 82% do not administer antibiotic prophylaxis routinely before VAD insertion. This practice is supported by the Guidelines for the Prevention of Intravascular Catheter-related Infections issued
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/12
Y1 - 2007/12
N2 - Introduction: There is limited information regarding of use of vascular access devices (VAD) in patients undergoing hematopoietic stem cell transplantation (HSCT). The frequent use of VAD in HSCT and its potential to cause morbidity requires understanding of the general use of VAD in HSCT. Materials and methods: A World Wide Web-based 19-item questionnaire was designed to determine the patterns of use of VAD in patients undergoing HSCT. The questionnaire was sent via electronic mail to the directors of HSCT programs throughout the world. Results: Of the 445 centers surveyed, 163 centers replied for a response rate of 37%. The most commonly used catheter for autologous peripheral blood stem cell (PBSC) harvest is the dual-lumen plasmapheresis/ hemodialysis (62%). Of the institutions, 58% utilize the same catheter used for PBSC harvest to provide vascular access support during the transplant. Catheter-related blood stream infection (36%) and withdrawal occlusion (31%) were the most frequently encountered complications of VAD. Of the centers, 65% have established criteria for VAD removal when infection is suspected and 48% when occlusion is suspected. Discussion: Our study demonstrated that there are similarities in the utilization of VAD but also wide differences in the standard procedures for the insertion and care of VAD in the transplant setting. More comprehensive studies are needed to assess the use of central venous catheters in transplant recipients. Important areas for future research include the impact of VAD utilization on the quality of life of transplant recipients and the final consequences of VAD complications.
AB - Introduction: There is limited information regarding of use of vascular access devices (VAD) in patients undergoing hematopoietic stem cell transplantation (HSCT). The frequent use of VAD in HSCT and its potential to cause morbidity requires understanding of the general use of VAD in HSCT. Materials and methods: A World Wide Web-based 19-item questionnaire was designed to determine the patterns of use of VAD in patients undergoing HSCT. The questionnaire was sent via electronic mail to the directors of HSCT programs throughout the world. Results: Of the 445 centers surveyed, 163 centers replied for a response rate of 37%. The most commonly used catheter for autologous peripheral blood stem cell (PBSC) harvest is the dual-lumen plasmapheresis/ hemodialysis (62%). Of the institutions, 58% utilize the same catheter used for PBSC harvest to provide vascular access support during the transplant. Catheter-related blood stream infection (36%) and withdrawal occlusion (31%) were the most frequently encountered complications of VAD. Of the centers, 65% have established criteria for VAD removal when infection is suspected and 48% when occlusion is suspected. Discussion: Our study demonstrated that there are similarities in the utilization of VAD but also wide differences in the standard procedures for the insertion and care of VAD in the transplant setting. More comprehensive studies are needed to assess the use of central venous catheters in transplant recipients. Important areas for future research include the impact of VAD utilization on the quality of life of transplant recipients and the final consequences of VAD complications.
KW - Catheter-related infection
KW - Catheter-related thrombosis
KW - Central venous catheter
KW - Health care surveys
KW - Hematopoietic stem cell transplantation
UR - http://www.scopus.com/inward/record.url?scp=35948970996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35948970996&partnerID=8YFLogxK
U2 - 10.1007/s00520-007-0261-8
DO - 10.1007/s00520-007-0261-8
M3 - Article
C2 - 17486374
AN - SCOPUS:35948970996
VL - 15
SP - 1375
EP - 1383
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
SN - 0941-4355
IS - 12
ER -